Education
About Us
Working with TipRanks
Follow Us
Cann Group Ltd. (AU:CAN)
ASX:CAN
CAN Stock Chart & Stats
AU$0.01
>-AU$0.01(-2.56%)
At close: 4:00 PM EST
AU$0.01
>-AU$0.01(-2.56%)
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.04
Previous CloseN/A
Volume350.31K
Average Volume (3M)5.26M
Market Cap
AU$12.71M
Enterprise ValueAU$19.78M
Total Cash (Recent Filing)AU$955.00K
Total Debt (Recent Filing)AU$15.10M
Price to Earnings (P/E)0.9
Beta0.29
Next Earnings
Aug 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding1,588,366,700
10 Day Avg. Volume7,033,578
30 Day Avg. Volume5,261,608
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-1.90
Price to Sales (P/S)0.40
P/FCF Ratio-0.54
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Integrated Supply ChainOwning cultivation, manufacturing and distribution provides durable operational control over product quality, regulatory compliance and supply reliability. This vertical integration can sustain margins, shorten time-to-market for new products, and support scaling into new markets over months.
Research Partnerships And LicensingActive collaborations and licensing efforts build a longer-term product pipeline and alternative revenue streams beyond patient sales. Such partnerships can lower R&D cost, accelerate clinical development, and create durable strategic options for commercial or co-development deals.
Positive Gross Margin At Product LevelA reported gross margin near 39% indicates product-level economics are viable, implying cost-efficient cultivation and processing. If overheads and operating losses are addressed, this gross profitability supports sustainable unit economics and potential profit conversion as revenue stabilises.
Bears Say
Negative Equity / Solvency RiskNegative shareholders' equity and extreme leverage signal structural solvency risk and constrain access to inexpensive capital. Over a multi-month horizon this limits strategic flexibility, increases refinancing risk, and may force dilutive or costly funding solutions to sustain operations.
Deep Operating Losses And Shrinking RevenueSteep revenue decline coupled with very large negative EBIT and net margins reflect structural profitability issues. Persistent operating losses reduce reinvestment capacity, require external funding or restructuring, and undermine long-term viability unless revenue trends reverse and costs are materially cut.
Negative Cash GenerationOngoing negative operating cash flow and deteriorating free cash flow growth indicate sustained cash burn. Over months this impairs the company's ability to fund operations internally, increases reliance on external financing, and raises execution risk for product development and market expansion plans.
Cann Group News
CAN FAQ
What was Cann Group Ltd.’s price range in the past 12 months?
Cann Group Ltd. lowest share price was <AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is Cann Group Ltd.’s market cap?
Cann Group Ltd.’s market cap is AU$12.71M.
When is Cann Group Ltd.’s upcoming earnings report date?
Cann Group Ltd.’s upcoming earnings report date is Aug 27, 2026 which is in 177 days.
How were Cann Group Ltd.’s earnings last quarter?
Cann Group Ltd. released its earnings results on Feb 27, 2026. The company reported AU$0.032 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.032.
Is Cann Group Ltd. overvalued?
According to Wall Street analysts Cann Group Ltd.’s price is currently Overvalued.
Does Cann Group Ltd. pay dividends?
Cann Group Ltd. does not currently pay dividends.
What is Cann Group Ltd.’s EPS estimate?
Cann Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cann Group Ltd. have?
Cann Group Ltd. has 1,588,366,700 shares outstanding.
What happened to Cann Group Ltd.’s price movement after its last earnings report?
Cann Group Ltd. reported an EPS of AU$0.032 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 16.667%.
Which hedge fund is a major shareholder of Cann Group Ltd.?
Currently, no hedge funds are holding shares in AU:CAN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cann Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bearish
AU:CAN Sentiment 70%
Sector Average 70%
Sector Average 70%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Fundamentals
Return on Equity
-401.36%
Trailing 12-Months
Asset Growth
-16.66%
Trailing 12-Months
Company Description
Cann Group Ltd.
Cann Group Limited (ASX: CAN) is an Australian biotechnology company specializing in the cultivation, production, and distribution of cannabis-based products for both medicinal and research purposes. The company operates in the cannabis sector, focusing on developing high-quality pharmaceutical-grade cannabis products. Cann Group is engaged in the entire supply chain, from cultivation and manufacturing to product distribution, and aims to meet the growing demand for legal cannabis products in Australia and international markets.